GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (NAS:GNFT) » Definitions » Float Percentage Of Total Shares Outstanding

Genfit (Genfit) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Genfit Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Genfit's float shares is 0.00 Mil. Genfit's total shares outstanding is 49.86 Mil. Genfit's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Genfit's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Genfit's Institutional Ownership is 0.01%.

Genfit Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Genfit's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/49.86
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genfit (Genfit) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (NAS:GNFT) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XPAR:TNG XPAR:MEDCL XPAR:AELIS XPAR:IVA XPAR:ALSEN XPAR:IPH XPAR:ADOC XPAR:DBV XPAR:OSE XPAR:NANO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
GNFTF:USA 0QT6:UK GNFT:France XUP:Germany
Address
Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120
Website
https://www.genfit.com
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.